Class III

Drug Recall: Abilify (aripiprazole), 5 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-007-13

Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. · April 9, 2024

Reason for Recall

Cross Contamination with Other Products

Distribution

USA nationwide.

States Affected

NATIONWIDE

Quantity Affected

108,192/30 count bottles or 7 count blister packs

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0466-2024

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.